Cargando…

Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers

Given sex‐related differences in brain disorders, it is of interest to study if there is a sex difference in the permeability of the blood‐cerebrospinal fluid barrier (BCSFB) and the blood‐brain barrier (BBB). The CSF/serum albumin ratio (Q(A) (lb)) is a standardized biomarker that evaluates the fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Parrado‐Fernández, Cristina, Blennow, Kaj, Hansson, Magnus, Leoni, Valerio, Cedazo‐Minguez, Angel, Björkhem, Ingemar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156389/
https://www.ncbi.nlm.nih.gov/pubmed/30054982
http://dx.doi.org/10.1111/jcmm.13767
_version_ 1783358091137384448
author Parrado‐Fernández, Cristina
Blennow, Kaj
Hansson, Magnus
Leoni, Valerio
Cedazo‐Minguez, Angel
Björkhem, Ingemar
author_facet Parrado‐Fernández, Cristina
Blennow, Kaj
Hansson, Magnus
Leoni, Valerio
Cedazo‐Minguez, Angel
Björkhem, Ingemar
author_sort Parrado‐Fernández, Cristina
collection PubMed
description Given sex‐related differences in brain disorders, it is of interest to study if there is a sex difference in the permeability of the blood‐cerebrospinal fluid barrier (BCSFB) and the blood‐brain barrier (BBB). The CSF/serum albumin ratio (Q(A) (lb)) is a standardized biomarker that evaluates the function of these barriers. In previous studies, contradictory results have been reported with respect to sex difference using this quotient, possibly because of small population sizes and heterogeneity with respect to ages. Q(A) (lb) measurements in more than 20 000 patients between 1 and 90 years visiting our hospitals revealed a significant sex difference in all age groups also when excluding patients with pathologically high CSF albumin > 400 mg/L. Similar pattern was found in 335 healthy volunteers in similar age intervals. Although also other factors are likely important, our observation is consistent with lower integrity of the brain barriers in males. If the difference in Q(A) (lb) is caused mainly by a difference in barrier function, this may require different drug doses and strategies for efficient central nervous system (CNS) delivery in males and females, as well as it may indicate differences in brain metabolism. Moreover, our study emphasizes that different reference values should be used both for different ages and sexes.
format Online
Article
Text
id pubmed-6156389
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61563892018-10-01 Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers Parrado‐Fernández, Cristina Blennow, Kaj Hansson, Magnus Leoni, Valerio Cedazo‐Minguez, Angel Björkhem, Ingemar J Cell Mol Med Short Communications Given sex‐related differences in brain disorders, it is of interest to study if there is a sex difference in the permeability of the blood‐cerebrospinal fluid barrier (BCSFB) and the blood‐brain barrier (BBB). The CSF/serum albumin ratio (Q(A) (lb)) is a standardized biomarker that evaluates the function of these barriers. In previous studies, contradictory results have been reported with respect to sex difference using this quotient, possibly because of small population sizes and heterogeneity with respect to ages. Q(A) (lb) measurements in more than 20 000 patients between 1 and 90 years visiting our hospitals revealed a significant sex difference in all age groups also when excluding patients with pathologically high CSF albumin > 400 mg/L. Similar pattern was found in 335 healthy volunteers in similar age intervals. Although also other factors are likely important, our observation is consistent with lower integrity of the brain barriers in males. If the difference in Q(A) (lb) is caused mainly by a difference in barrier function, this may require different drug doses and strategies for efficient central nervous system (CNS) delivery in males and females, as well as it may indicate differences in brain metabolism. Moreover, our study emphasizes that different reference values should be used both for different ages and sexes. John Wiley and Sons Inc. 2018-07-27 2018-10 /pmc/articles/PMC6156389/ /pubmed/30054982 http://dx.doi.org/10.1111/jcmm.13767 Text en © 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communications
Parrado‐Fernández, Cristina
Blennow, Kaj
Hansson, Magnus
Leoni, Valerio
Cedazo‐Minguez, Angel
Björkhem, Ingemar
Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers
title Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers
title_full Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers
title_fullStr Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers
title_full_unstemmed Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers
title_short Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers
title_sort evidence for sex difference in the csf/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156389/
https://www.ncbi.nlm.nih.gov/pubmed/30054982
http://dx.doi.org/10.1111/jcmm.13767
work_keys_str_mv AT parradofernandezcristina evidenceforsexdifferenceinthecsfplasmaalbuminratioin20000patientsand335healthyvolunteers
AT blennowkaj evidenceforsexdifferenceinthecsfplasmaalbuminratioin20000patientsand335healthyvolunteers
AT hanssonmagnus evidenceforsexdifferenceinthecsfplasmaalbuminratioin20000patientsand335healthyvolunteers
AT leonivalerio evidenceforsexdifferenceinthecsfplasmaalbuminratioin20000patientsand335healthyvolunteers
AT cedazominguezangel evidenceforsexdifferenceinthecsfplasmaalbuminratioin20000patientsand335healthyvolunteers
AT bjorkhemingemar evidenceforsexdifferenceinthecsfplasmaalbuminratioin20000patientsand335healthyvolunteers